This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 21 and 55
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purpose of this study is to investigate the time course of PF-04764793 concentration in the blood following dosing by oral inhalation from dry powder inhalers.

Provided treatments

  • Drug: Treatment A
  • Drug: Treatment B
  • Drug: Treatment C
  • Drug: Treatment D
Tris trial is registered with FDA with number: NCT00928278. The sponsor of the trial is Pfizer and it is looking for 36 volunteers for the current phase.
Official trial title:
An Open Study To Estimate The Plasma Pharmacokinetics Of PF-04764793 Administered Via Oral Inhalation Using Dry Powder Inhalers.